This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
September 6, 2012 5:00 p.m. ET
Tom Rathjen - VP of IR
Euan Thomson - President and CEO
Derek Bertocci - SVP and CFO
Raj Denhoy - Jefferies
Steve [Busha] - Morgan Stanley
Tycho Peterson - JP Morgan
Charles [Crawson] - Sidoti & Company
Junaid Hussein - Dougherty & Company
Good day ladies and gentlemen, and welcome to the fourth quarter 2012 Accuray Incorporated earnings conference call. [Operator instructions.] I would now like to turn the conference over to Mr. Tom Rathjen, vice president of investor relations. Please go ahead sir.
Thank you operator. Hello, and thank you for joining our conference call this afternoon as we review Accuray’s fourth quarter and fiscal year 2012. Joining us today are Dr. Euan Thomson, Accuray's president and chief executive officer; and Derek Bertocci, Accuray's senior vice president and chief financial officer.
Please note that today we will be referring to financial data which can be found in a summary slide deck on the investor relations page of the Accuray website at accuray.com/investors.
Before we begin, I need to remind you that our presentation includes forward-looking statements that involve risks and uncertainties. There are a number of factors that could cause actual risks and uncertainties to differ materially from our expectations, including risks related to our ability to achieve projected revenue, gross margin, and profitability targets, achieve our TomoTherapy integration goals, launch new technologies, and improve performance in the U.S. through a realignment of our sales organization.
These and other risks are more fully described in the press release we issued earlier this afternoon, our form 10-K for fiscal 2012, which will be filed shortly, and other filings with the Securities and Exchange Commission. We assume no obligation to update any forward looking statements.